Form 4: Edwards Lifesciences Director Valeriani Receives Stock Grant
SEC Form 4 Filing
Nicholas J. Valeriani, a director at Edwards Lifesciences, acquired 4,818 shares of common stock through a restricted stock unit grant.
Summary
- On May 8, 2024, Nicholas J. Valeriani, a director of Edwards Lifesciences Corp, received a grant of 4,818 restricted stock units.
- These restricted stock units were granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.
- The restricted stock units will vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
- Following the transaction, Valeriani directly owns 73,732 shares of Edwards Lifesciences common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine stock grant to a director, which is generally viewed as a neutral to slightly positive event as it aligns management interests with shareholders.
Positives
- The grant of restricted stock units aligns the director's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the director.
Future Outlook
The restricted stock units will vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
Industry Context
Stock grants to directors are a common practice in publicly traded companies to incentivize and align their interests with shareholders.
Comparison to Industry Standards
- Director compensation packages, including stock grants, vary significantly across the medical device industry.
- Companies like Medtronic and Abbott also utilize stock grants as part of their director compensation plans.
- The size of the grant is typical for a director at a company of Edwards Lifesciences' size and market capitalization.
Stakeholder Impact
- The stock grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.
- The vesting schedule encourages long-term commitment from the director, which can benefit the company and its stakeholders.
Key Dates
| Date | Description |
|---|---|
| 05/08/2024 | Date of restricted stock unit grant |
| 05/09/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.